Japan Bioanalytical Testing Services Market Insights Forecasts to 2033

• The Japan Bioanalytical Testing Services Market Size was valued at USD 67.5 Million in 2023.
• The Market is Growing at a CAGR of 11.01% from 2023 to 2033
• The Japan Bioanalytical Testing Services Market Size is Expected to Reach USD 191.91 Million by 2033

The Japan Bioanalytical Testing Services Market Size is Anticipated to Exceed USD 191.91 Million by 2033, Growing at a CAGR of 11.01% from 2023 to 2033.

Market Overview

A biological form of a chemical substance is collected, processed, stored, and analyzed using a set of steps known as a bioanalytical method. The process of determining if a quantitative analytical method is appropriate for use in biochemical applications is known as bioanalytical method validation or BMV. Bioanalysis is the quantitative assessment of biological molecules in abnormal locations or concentrations, large molecule pharmaceuticals, macromolecules, proteins, DNA, and metabolites in biological systems, as well as xenobiotics of drugs such as their metabolites. Its main objective is to assess novel therapeutic compounds for safety, toxicity, and efficacy. It seems expected that increased focus on developing advanced bioanalytical technologies for better testing will aid in market growth. The advent of combination products, biosimilars, and other innovative medications has led to a rise in the need for specific testing techniques.

Report Coverage

This research report categorizes the market for Japan bioanalytical testing services market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan bioanalytical testing services market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan bioanalytical testing services market.

Driving Factors

The market is primarily driven by factors including the growing acceptance of the quality-by-design approach and the growing demand for outsourcing analytical testing. Japan is among the nations with one of the most advanced pharmaceutical industries. In Japan, the market for contract development manufacturing organizations, or CDMOs, is growing with the study and development of different medications. Due to this, there is an increasing need for analytical testing to be outsourced, which should promote market expansion. Businesses can send out more difficult or repetitive jobs while maintaining focus on their core capabilities due to outsourcing. As a result, businesses can save money by not having to hire employees or construct specialized facilities.

Restraining Factors

One of the main factors anticipated to impede the growth of this market is the lack of qualified personnel to operate the sophisticated equipment needed for bioanalytical testing. The pricing pressure on companies is somewhat increased since these local or regional analytical testing service providers provide services at a cheaper cost than well-known bioanalytical testing service providers.

Market Segmentation

The Japan bioanalytical testing services market share is classified into molecule type and application.

• The small molecule bioanalysis segment is anticipated to hold a significant share of the Japan bioanalytical testing services market during the forecast period.       

Based on the molecule type, the Japan bioanalytical testing services market is divided into small molecule bioanalysis, large molecule bioanalysis, and others. Among these, the small molecule bioanalysis segment is anticipated to hold a significant share of the Japan bioanalytical testing services market during the forecast period. This is due to small-molecule bioanalysis provides advantages such as range, selectivity, sensitivity, dynamics, and resilience, all of which are critical for modern drug development procedures.

• The oncology segment is anticipated to hold a significant share of the Japan bioanalytical testing services market during the forecast period.       

Based on the application, the Japan bioanalytical testing services market is divided into oncology, neurology, infectious diseases, gastroenterology, cardiology, and others. Among these, the oncology segment is anticipated to hold a significant share of the Japan bioanalytical testing services market during the forecast period. The increasing number of cancer cases worldwide and the expansion of oncology clinical trials are to blame for this segment's growth. Additionally, the market's segment expansion will be fueled by the aging population and dropping birthrate.   

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan bioanalytical testing services market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• SRL, Inc.
• Mitsubishi Chemical Medience Corporation
• LSI Medience Corporation
• LSI Medience Clinical Laboratory, Inc.
• BML, Inc.
• Mitsubishi Chemical Analytech Co., Ltd.
• Tosoh Medics, Inc.
• Sekisui Medical Co., Ltd.
• Soiken Holdings Inc.
• Kishimoto Kensetsu Sangyo Co., Ltd.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In February 2023, The website for the "KAITEKI Future Lab." brand was recently changed to the "KAITEKI Solution Center." This modification is in line with the new Group Concept, which emphasizes the application of creative solutions.

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Japan Bioanalytical Testing Services Market based on the below-mentioned segments:

Japan Bioanalytical Testing Services Market, By Molecule Type

• Small Molecule Bioanalysis
• Large Molecule Bioanalysis
• Others

Japan Bioanalytical Testing Services Market, By Application

• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology
• Others